Stem cells to treat muscular dystrophies – Where are we? (Q37807624)

23 August 2017

title

Stem cells to treat muscular dystrophies - where are we? (English)

1 reference

23 August 2017

Stem cells to treat muscular dystrophies – Where are we? (English)

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

21 August 2024

2

Francesco Muntoni

1 reference

23 August 2017

Jinhong Meng

1

1 reference

23 August 2017

Jennifer E. Morgan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21055938

21 August 2024

language of work or name

1 reference

4 November 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0960896610006346?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

https://api.elsevier.com/content/article/PII:S0960896610006346?httpAccept=text/plain

21 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

21 August 2024

published in

Neuromuscular Disorders

1 reference

23 August 2017

volume

21

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

4-12

1 reference

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

23 August 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.CELL.2007.11.019

Heat shock pretreatment enhances porcine myoblasts survival after autotransplantation in intact skeletal muscle

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1007/S11427-007-0065-6

Coexistence of quiescent and active adult stem cells in mammals

1

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

21 August 2024

Stem Cells

2

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Epidermal keratinocyte stem cells: their maintenance and regulation

21 August 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche.

21 August 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Niche regulation of muscle satellite cell self-renewal and differentiation

21 August 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Satellite cell of skeletal muscle fibers

21 August 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

The structure of the satellite cells in skeletal muscle

21 August 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

All muscle satellite cells are equal, but are some more equal than others?

21 August 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Regulation of satellite cells during skeletal muscle growth and development

21 August 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

A new look at the origin, function, and "stem-cell" status of muscle satellite cells

21 August 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Potentiation of myoblast transplantation by host muscle irradiation is dependent on the rate of radiation delivery

21 August 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation

21 August 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Dystrophin expression in the mdx mouse restored by stem cell transplantation

21 August 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Nondystrophic myoblast transplantation into dystrophic muscle

21 August 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation

21 August 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts

21 August 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Investigating the pathology of Emery-Dreifuss muscular dystrophy

21 August 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Genetic heterogeneity in Duchenne muscular dystrophy

21 August 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Muscular dystrophies due to glycosylation defects

21 August 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Molecular signatures of Emery-Dreifuss muscular dystrophy

21 August 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy

21 August 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

β–sarcoglycan: characterization and role in limb–girdle muscular dystrophy linked to 4q12

21 August 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Abnormalities in alpha-, beta- and gamma-sarcoglycan in patients with limb-girdle muscular dystrophy

21 August 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Prenatal diagnosis in laminin alpha2 chain (merosin)-deficient congenital muscular dystrophy: a collective experience of five international centers.

21 August 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Amelioration of laminin-alpha2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin

21 August 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Muscle interstitial fibroblasts are the main source of collagen VI synthesis in skeletal muscle: implications for congenital muscular dystrophy types Ullrich and Bethlem

21 August 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Does satellite cell dysfunction contribute to disease progression in Emery-Dreifuss muscular dystrophy?

21 August 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Multiple roles for emerin: implications for Emery-Dreifuss muscular dystrophy

21 August 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Structural analysis of emerin, an inner nuclear membrane protein mutated in X-linked Emery-Dreifuss muscular dystrophy

21 August 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

How does dystrophin deficiency lead to muscle degeneration?--evidence from the mdx mouse

21 August 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse

21 August 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

A quantitative study of myonuclear and satellite cell nuclear size in Duchenne's muscular dystrophy, polymyositis and normal human skeletal muscle

21 August 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Deficiency of dystrophin-associated proteins: a common mechanism leading to muscle cell necrosis in severe childhood muscular dystrophies

21 August 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

21 August 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion

21 August 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Muscle regeneration by bone marrow-derived myogenic progenitors

21 August 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development

21 August 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Regeneration of skeletal muscle from transplanted immortalised myoblasts is oligoclonal

21 August 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Myogenic cell proliferation and generation of a reversible tumorigenic phenotype are triggered by preirradiation of the recipient site

21 August 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Patterns of repair of dystrophic mouse muscle: studies on isolated fibers

21 August 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Human Muscle Precursor Cell Regeneration in the Mouse Host Is Enhanced by Growth Factors

21 August 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Human muscle precursor cells give rise to functional satellite cells in vivo

21 August 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

The contribution of human synovial stem cells to skeletal muscle regeneration

21 August 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Mature adult dystrophic mouse muscle environment does not impede efficient engrafted satellite cell regeneration and self-renewal.

21 August 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

21 August 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Satellite cell depletion in degenerative skeletal muscle

21 August 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Generation of transplantable, functional satellite-like cells from mouse embryonic stem cells

21 August 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells

21 August 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

A population of myogenic stem cells that survives skeletal muscle aging.

21 August 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Muscle precursor cells injected into irradiated mdx mouse muscle persist after serial injury.

21 August 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin

21 August 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Enhanced exon-skipping induced by U7 snRNA carrying a splicing silencer sequence: Promising tool for DMD therapy

21 August 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice

21 August 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Lentiviral vectors in gene therapy: their current status and future potential

21 August 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Dystrophin delivery to muscles of mdx mice using lentiviral vectors leads to myogenic progenitor targeting and stable gene expression.

21 August 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

State-of-the-art lentiviral vectors for research use: risk assessment and biosafety recommendations

21 August 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

In vivo manipulation of gene expression in non-human primates using lentiviral vectors as delivery vehicles

21 August 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Progress and problems with the use of viral vectors for gene therapy

21 August 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Insertional gene activation by lentiviral and gammaretroviral vectors.

21 August 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

21 August 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Strong muscle-specific regulatory cassettes based on multiple copies of the human slow troponin I gene upstream enhancer

21 August 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

The short MCK1350 promoter/enhancer allows for sufficient dystrophin expression in skeletal muscles of mdx mice

21 August 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Expression of dystrophin driven by the 1.35-kb MCK promoter ameliorates muscular dystrophy in fast, but not in slow muscles of transgenic mdx mice

21 August 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Desmin-regulated lentiviral vectors for skeletal muscle gene transfer

21 August 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Transposons for gene therapy!

21 August 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Gene therapy vectors: the prospects and potentials of the cut-and-paste transposons

21 August 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Efficient stable gene transfer into human cells by the Sleeping Beauty transposon vectors.

21 August 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Novel hyperactive transposons for genetic modification of induced pluripotent and adult stem cells: a nonviral paradigm for coaxed differentiation.

21 August 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

A highly stable and nonintegrated human artificial chromosome (HAC) containing the 2.4 Mb entire human dystrophin gene

21 August 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Complete genetic correction of ips cells from Duchenne muscular dystrophy

21 August 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Partial correction of an inherited biochemical defect of skeletal muscle by grafts of normal muscle precursor cells

21 August 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

X chromosome-linked muscular dystrophy (mdx) in the mouse

21 August 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy

21 August 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Dystrophin delivery in dystrophin-deficient DMDmdx skeletal muscle by isogenic muscle-derived stem cell transplantation

21 August 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

X-irradiation improves mdx mouse muscle as a model of myofiber loss in DMD

21 August 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs

21 August 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy

21 August 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies

21 August 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells

21 August 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

A serum-free medium that supports the growth of cultured skeletal muscle satellite cells

21 August 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Proliferation of muscle satellite cells on intact myofibers in culture

21 August 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Human myoblast transplantation in immunodeficient and immunosuppressed mice: evidence of rejection

21 August 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Myoblast transfer therapy: is there any light at the end of the tunnel?

21 August 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Problems and solutions in myoblast transfer therapy.

21 August 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Direct isolation of satellite cells for skeletal muscle regeneration

21 August 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Cell Therapy of -Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of Mesoangioblasts

21 August 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

New therapies for muscular dystrophy: cautious optimism

21 August 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Lack of myoblasts migration between transplanted and host muscles of mdx and normal mice

21 August 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Cell transplantation and gene therapy in muscular dystrophy

21 August 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Long-term persistence and migration of myogenic cells injected into pre-irradiated muscles of mdx mice

21 August 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Overexpression of follistatin in human myoblasts increases their proliferation and differentiation, and improves the graft success in SCID mice

21 August 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Myoblast survival enhancement and transplantation success improvement by heat-shock treatment in mdx mice

21 August 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Growth factor coinjection improves the migration potential of monkey myogenic precursors without affecting cell transplantation success

21 August 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Human myoblast engraftment is improved in laminin-enriched microenvironment.

21 August 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

The fate of individual myoblasts after transplantation into muscles of DMD patients

21 August 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Myoblast Transfer in the Treatment of Duchenne's Muscular Dystrophy

21 August 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Myoblast implantation in Duchenne muscular dystrophy: the San Francisco study.

21 August 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy.

21 August 2024

103

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

First test of a "high-density injection" protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up

21 August 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells.

21 August 2024

105

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells

21 August 2024

106

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Muscle-derived stem cells: potential for muscle regeneration

21 August 2024

107

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration

21 August 2024

108

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Myogenic specification of side population cells in skeletal muscle

21 August 2024

109

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Prospective identification of myogenic endothelial cells in human skeletal muscle

21 August 2024

110

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Allogeneic mesoangioblasts give rise to alpha-sarcoglycan expressing fibers when transplanted into dystrophic mice

21 August 2024

111

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs

21 August 2024

112

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

In vivo myogenic potential of human CD133 muscle-derived stem cells: a quantitative study

21 August 2024

113

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells

21 August 2024

115

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Widespread distribution and muscle differentiation of human fetal mesenchymal stem cells after intrauterine transplantation in dystrophic mdx mouse

21 August 2024

116

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Bone marrow stromal cells generate muscle cells and repair muscle degeneration.

21 August 2024

117

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Myogenic fusion of human bone marrow stromal cells, but not hematopoietic cells

21 August 2024

118

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

c-Kit function is necessary for in vitro myogenic differentiation of bone marrow hematopoietic cells.

21 August 2024

119

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood

21 August 2024

120

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Acceleration of skeletal muscle regeneration in a rat skeletal muscle injury model by local injection of human peripheral blood-derived CD133-positive cells

21 August 2024

121

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Human circulating AC133( ) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle

21 August 2024

122

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates

21 August 2024

123

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Contribution of hematopoietic stem cells to skeletal muscle

21 August 2024

124

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective?

21 August 2024

125

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials.

21 August 2024

126

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs

21 August 2024

127

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Transplanted hematopoietic stem cells demonstrate impaired sarcoglycan expression after engraftment into cardiac and skeletal muscle.

21 August 2024

128

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Isolation of adult mouse myogenic progenitors: functional heterogeneity of cells within and engrafting skeletal muscle.

21 August 2024

129

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane.

21 August 2024

130

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes

21 August 2024

131

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Transplantation of Dermal Fibroblasts Expressing MyoD1 in Mouse Muscles

21 August 2024

132

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Conversion of dermal fibroblasts to a myogenic lineage is induced by a soluble factor derived from myoblasts

21 August 2024

133

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Immortalized Skin Fibroblasts Expressing Conditional MyoD as a Renewable and Reliable Source of Converted Human Muscle Cells to Assess Therapeutic Strategies for Muscular Dystrophies: Validation of an Exon-Skipping Approach to Restore Dystrophin in D

21 August 2024

134

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies

21 August 2024

135

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy.

21 August 2024

136

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Risk of tumorigenesis in first-in-human trials of embryonic stem cell neural derivatives: Ethics in the face of long-term uncertainty

21 August 2024

137

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Derivation of multipotent mesenchymal precursors from human embryonic stem cells

21 August 2024

138

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Derivation of engraftable skeletal myoblasts from human embryonic stem cells

21 August 2024

139

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Generation of skeletal muscle from transplanted embryonic stem cells in dystrophic mice

21 August 2024

140

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Functional skeletal muscle regeneration from differentiating embryonic stem cells

21 August 2024

141

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Engraftment of embryonic stem cell-derived myogenic progenitors in a dominant model of muscular dystrophy

21 August 2024

142

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Alternative sources of pluripotency: science, ethics, and stem cells

21 August 2024

143

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 August 2024

144

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Induction of pluripotent stem cells from fibroblast cultures

21 August 2024

146

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Human induced pluripotent stem cells on autologous feeders

21 August 2024

147

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Immortalized human skin fibroblast feeder cells support growth and maintenance of both human embryonic and induced pluripotent stem cells

21 August 2024

148

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Purification and cell-surface marker characterization of quiescent satellite cells from murine skeletal muscle by a novel monoclonal antibody.

21 August 2024

149

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Feasibility, safety, and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boys

21 August 2024

150

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

21 August 2024

The muscular dystrophies

151

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Is myoblast transplantation effective?

21 August 2024

152

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Autologous Transplantation of Muscle-Derived CD133 Stem Cells in Duchenne Muscle Patients

21 August 2024

153

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

Self-renewal and expansion of single transplanted muscle stem cells

21 August 2024

154

1 reference

https://api.crossref.org/works/10.1016/J.NMD.2010.10.004

21 August 2024

Identifiers

1 reference

23 August 2017

1 reference